PTC Therapeutics, Huntington's disease and Fast Track
PTC Therapeutics' Huntington's Treatment Gets FDA Fast Track Designation
PTC Therapeutics' treatment for Huntington's disease has received a fast track designation from U.S. health regulators. The biopharmaceutical company said Thursday that the Food and Drug Administration granted the designation to the PTC518 program which aims to reduce the production of mutated Huntington protein.
FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program
PTC Therapeutics (NASDAQ: PTCT) announced today that the FDA has granted Fast Track designation to the PTC518 program for the treatment of Huntington's disease. Fast Track designation is awarded to promising therapies for diseases of high unmet need.
Hundreds of walkers will lace up their shoes this weekend to raise money to battle Alzheimer’s and Huntington’s Disease.
GlobalData on MSN10d
Vico reports positive data from trial of VO659 for Huntington’s diseaseThe data shows a significant reduction in mutant huntingtin protein in the cerebrospinal fluid of treated patients.
Innovative treatments using TRIM21 have successfully targeted tau aggregates in Alzheimer’s, showing potential for broader ...
Aug. 22, 2024 — Researchers have implicated a new gene in the progression of Huntington's disease in a brain organoid model. The gene may contribute to brain abnormalities much earlier than ...
PORTLAND, Ore. ( KOIN) — You can lace up and show your support for those living with Huntington’s disease at the 2024 Team ...
The Kentucky Chapter of the Huntington's Disease Society of America hosted the Team Hope Walk Sunday afternoon at Waterfront ...
WASHINGTON (AP) — Retired NFL quarterback Brett Favre has been diagnosed with Parkinson’s disease, he told a congressional ...
Vince Gilmer, a former Western North Carolina doctor, was sentenced to life in prison for the 2004 killing of his father.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback